标题
Improving risk‐stratification of natalizumab‐associated PML
作者
关键词
-
出版物
Annals of Clinical and Translational Neurology
Volume 8, Issue 3, Pages 696-703
出版商
Wiley
发表日期
2021-02-08
DOI
10.1002/acn3.51130
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Long-term safety and effectiveness of natalizumab treatment in clinical practice: 10 years of real-world data from the Tysabri Observational Program (TOP)
- (2020) Helmut Butzkueven et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Evaluation of natalizumab pharmacokinetics and pharmacodynamics with standard and extended interval dosing
- (2019) John F. Foley et al. Multiple Sclerosis and Related Disorders
- The risk of PML from natalizumab – Authors' reply
- (2019) Pei-Ran Ho et al. LANCET NEUROLOGY
- Should frequent MRI monitoring be performed in natalizumab-treated MS patients? A contribution to a recent debate
- (2019) Cristina Scarpazza et al. Multiple Sclerosis Journal
- Natalizumab-associated progressive multifocal leukoencephalopathy in Germany
- (2019) Kira Blankenbach et al. NEUROLOGY
- Treatment of natalizumab‐associated PML with filgrastim
- (2019) Dusan Stefoski et al. Annals of Clinical and Translational Neurology
- Prospective validation of the PML risk biomarker l-selectin and influence of natalizumab extended intervals
- (2019) Nicholas Schwab et al. NEUROLOGY
- Progressive Multifocal Leukoencephalopathy Incidence and Risk Stratification Among Natalizumab Users in France
- (2019) Sandra Vukusic et al. JAMA Neurology
- The 5-year Tysabri Global Observational Program in Safety (TYGRIS) study confirms the long-term safety profile of natalizumab treatment in multiple sclerosis
- (2019) John Foley et al. Multiple Sclerosis and Related Disorders
- Pathogenesis of progressive multifocal leukoencephalopathy and risks associated with treatments for multiple sclerosis: a decade of lessons learned
- (2018) Eugene O Major et al. LANCET NEUROLOGY
- Early diagnosis of progressive multifocal leucoencephalopathy: longitudinal lesion evolution
- (2018) Cristina Scarpazza et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Impact of Disease-Modifying Treatments on the Longitudinal Evolution of Anti-JCV Antibody Index in Multiple Sclerosis
- (2018) Harald Hegen et al. Frontiers in Immunology
- Natalizumab therapy is associated with changes in serum JC virus antibody indices over time
- (2017) John Peters et al. JOURNAL OF NEUROLOGY
- Risk of natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: a retrospective analysis of data from four clinical studies
- (2017) Pei-Ran Ho et al. LANCET NEUROLOGY
- Anti-JCV serology during natalizumab treatment: Review and meta-analysis of 17 independent patient cohorts analyzing anti-John Cunningham polyoma virus sero-conversion rates under natalizumab treatment and differences between technical and biological sero-converters
- (2017) Nicholas Schwab et al. Multiple Sclerosis Journal
- PML in natalizumab-treated multiple sclerosis
- (2017) Ellen M. Mowry et al. NEUROLOGY
- Anti-JCV serology during natalizumab treatment: Review and meta-analysis of 17 independent patient cohorts analyzing anti-John Cunningham polyoma virus sero-conversion rates under natalizumab treatment and differences between technical and biological sero-converters
- (2017) Nicholas Schwab et al. Multiple Sclerosis Journal
- Longitudinal JCV serology in multiple sclerosis patients preceding natalizumab-associated progressive multifocal leukoencephalopathy
- (2015) Anke Vennegoor et al. Multiple Sclerosis Journal
- Longitudinal JCV serology in multiple sclerosis patients preceding natalizumab-associated progressive multifocal leukoencephalopathy
- (2015) Anke Vennegoor et al. Multiple Sclerosis Journal
- Anti-JC virus antibody levels in serum or plasma further define risk of natalizumab-associated progressive multifocal leukoencephalopathy
- (2014) Tatiana Plavina et al. ANNALS OF NEUROLOGY
- MS disease activity in RESTORE: A randomized 24-week natalizumab treatment interruption study
- (2014) R. J. Fox et al. NEUROLOGY
- Long-term safety and effectiveness of natalizumab redosing and treatment in the STRATA MS Study
- (2014) P. O'Connor et al. NEUROLOGY
- Outcome and survival of asymptomatic PML in natalizumab-treated MS patients
- (2014) Tuan Dong-Si et al. Annals of Clinical and Translational Neurology
- PML diagnostic criteria: Consensus statement from the AAN Neuroinfectious Disease Section
- (2013) J. R. Berger et al. NEUROLOGY
- Classification of Natalizumab Cases with Progressive Multifocal Leukoencephalopathy (P07.058)
- (2012) T. Dong-Si et al. NEUROLOGY
- Risk of Natalizumab-Associated Progressive Multifocal Leukoencephalopathy
- (2012) Gary Bloomgren et al. NEW ENGLAND JOURNAL OF MEDICINE
- Anti-John Cunnigham virus antibody prevalence in multiple sclerosis patients: Baseline results of STRATIFY-1
- (2011) Carmen Bozic et al. ANNALS OF NEUROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now